These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1827854

  • 41. Photodynamic toxicity of hematoporphyrin derivatives to human keratinocytes in culture.
    Kappus H, Reinhold C, Artuc M.
    Mol Toxicol; ; 1(4):295-9. PubMed ID: 2476672
    [Abstract] [Full Text] [Related]

  • 42. [Comparison on the biological activity of three home-made HpDs with that of photofrin II].
    Han R, Xu CX, Li ZR, Cheng YS, Du CZ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):159-64. PubMed ID: 2946453
    [No Abstract] [Full Text] [Related]

  • 43. [A comparative study on the photodynamic effect, photosensitive side action and toxicity of several China-made photosensitizers].
    Wang NQ, Yu G, Liang YY, Ye AL, Zhang Y, Yuan QZ.
    Yao Xue Xue Bao; 1986 Jan; 21(1):7-11. PubMed ID: 2425553
    [No Abstract] [Full Text] [Related]

  • 44. Distribution of hematoporphyrin derivative in canine glioma following intraneoplastic and intraperitoneal injection.
    Steichen JD, Dashner K, Martuza RL.
    J Neurosurg; 1986 Sep; 65(3):364-9. PubMed ID: 2942650
    [Abstract] [Full Text] [Related]

  • 45. In vivo canine coronary artery laser irradiation: photodynamic therapy using dihematoporphyrin ether and 632 nm laser. A safety and dose-response relationship study.
    Mackie RW, Vincent GM, Fox J, Orme EC, Hammond EH, Chang-Zong C, Johnson MD.
    Lasers Surg Med; 1991 Sep; 11(6):535-44. PubMed ID: 1836521
    [Abstract] [Full Text] [Related]

  • 46. [Hematoporphyrin derivative (HpD) and laser therapy in the management of malignant tumors--clinical analysis of 47 cases].
    Ha XW.
    Zhonghua Yi Xue Za Zhi; 1983 Jun; 63(6):322-5. PubMed ID: 6226341
    [No Abstract] [Full Text] [Related]

  • 47. Experimental studies of photodynamic therapy in a retinoblastoma-like tumour.
    Winther J, Overgaard J.
    Acta Ophthalmol Suppl (1985); 1987 Jun; 182():140-3. PubMed ID: 2837049
    [Abstract] [Full Text] [Related]

  • 48. Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light.
    Tochner Z, Mitchell JB, Harrington FS, Smith P, Russo DT, Russo A.
    Cancer Res; 1985 Jul; 45(7):2983-7. PubMed ID: 4005837
    [Abstract] [Full Text] [Related]

  • 49. The clinical treatment of laryngeal papillomas with hematoporphyrin therapy.
    Abramson AL, Waner M, Brandsma J.
    Arch Otolaryngol Head Neck Surg; 1988 Jul; 114(7):795-800. PubMed ID: 2838053
    [Abstract] [Full Text] [Related]

  • 50. Experimental photodynamic treatment of canine bladder.
    Nseyo UO, Dougherty TJ, Boyle D, Potter W, Englander LS, Huben RP, Pontes JE.
    J Urol; 1985 Feb; 133(2):311-5. PubMed ID: 3155804
    [Abstract] [Full Text] [Related]

  • 51. [Molecular biological mechanisms of photodynamic therapy].
    Kirvialene VA, Lukshene ZhB, Iuodka BA.
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1989 Feb; (5):5-14. PubMed ID: 2527567
    [Abstract] [Full Text] [Related]

  • 52. Comparative study between pulsed and continuous wave lasers for Photofrin photodynamic therapy.
    Panjehpour M, Overholt BF, DeNovo RC, Petersen MG, Sneed RE.
    Lasers Surg Med; 1993 Feb; 13(3):296-304. PubMed ID: 8515669
    [Abstract] [Full Text] [Related]

  • 53. The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis.
    Gomer CJ, Ferrario A, Murphree AL.
    Br J Cancer; 1987 Jul; 56(1):27-32. PubMed ID: 2956984
    [Abstract] [Full Text] [Related]

  • 54. Global status of clinical photodynamic therapy: the registration process for a new therapy.
    Marcus SL, Dugan MH.
    Lasers Surg Med; 1992 Jul; 12(3):318-24. PubMed ID: 1387186
    [Abstract] [Full Text] [Related]

  • 55. [Improved argon laser photodynamic therapy for superficial bladder tumor--experimental research and clinical analysis].
    Guo YC.
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):75-7. PubMed ID: 2142071
    [Abstract] [Full Text] [Related]

  • 56. Action spectrum (620-640 nm) for hematoporphyrin derivative induced cell killing.
    Gomer CJ, Doiron DR, Rucker N, Razum NJ, Fountain SW.
    Photochem Photobiol; 1984 Mar; 39(3):365-8. PubMed ID: 6232630
    [No Abstract] [Full Text] [Related]

  • 57. Clinical use of hematoporphyrin derivative in malignant tumors.
    Ha XW, Sun XM, Xie JG, Fan XJ, Zhang YH, Mei QC, Shen H, Xu SL, Zhang RG.
    Chin Med J (Engl); 1983 Oct; 96(10):754-8. PubMed ID: 6233105
    [No Abstract] [Full Text] [Related]

  • 58. Experimental study on cytotoxic effects of hyperbaric oxygen and photodynamic therapy on mouse transplanted tumor.
    Dong GC, Hu SX, Zhao GY, Gao SZ, Wu LR.
    Chin Med J (Engl); 1987 Sep; 100(9):697-702. PubMed ID: 2964998
    [No Abstract] [Full Text] [Related]

  • 59. Wavelength dependence of hematoporphyrin derivative photodynamic treatment effects on rat ears.
    Star W, Versteeg J, van Putten W, Marijnissen H.
    Photochem Photobiol; 1990 Sep; 52(3):547-54. PubMed ID: 2149462
    [Abstract] [Full Text] [Related]

  • 60. The photodynamic effects of photofrin II, hematoporphyrin derivative, hematoporphyrin, and tetrasodium-mesotetra(4-sulfonatophenyl)porphine in vitro: clonogenic cell survival and drug uptake studies.
    West CM, Moore JV.
    Photochem Photobiol; 1989 Feb; 49(2):169-74. PubMed ID: 2523543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.